Sarepta Issues Statement on ELEVIDYS Patient Death
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued...
BeOne’s TEVIMBRA Gets CHMP Nod for NSCLC Treatment
Recommendation based on Phase 3 RATIONALE-315 study, in which TEVIMBRA demonstrated clinically meaningful and statistically...
Malaysia Launches MYMT 2026, Its 1st Medical Tourism Year
The Malaysia Healthcare Travel Council (MHTC) launched Malaysia Year of Medical Tourism (MYMT) 2026 today at the...
IDEAYA & Hengrui to Present IDE849 at IASLC 2025 Lung Cancer Conf
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, and Jiangsu Hengrui Pharmaceuticals Co.,...
Humana Speeds Up Prior Authorization Removal for Faster Care
New effort will expedite approvals, promote access to care, reduce administrative burdens, and enhance the...
MVP Health & Renalytix Partner to Expand Kidney Disease Testing
New partnership expands access to prognostic testing for people with diabetic kidney disease, helping improve...